Acute Kidney Injury in Patients Receiving Anti-Tuberculosis Treatment

Autori

  • Madiha Mehmood Department of Nephrology, King Edward Medical Universiy, Lahore, Pakistan
  • Muhammad Anees Department of Nephrology, King Edward Medical Universiy, Lahore, Pakistan

DOI:

https://doi.org/10.53778/pjkd92302

Cuvinte cheie:

acute kidney injury, anti tuberculous treatment, ATT, Rifampicin, Isoniazid, AKI

Rezumat

Although life-saving, anti-tuberculosis therapy (ATT) carries the risk of acute kidney injury (AKI), potentially complicating its management.

 

Methods: 102 subjects starting on ATT were followed for 2 months. Presence of AKI was documented with monitoring of kidney functions.

Results:

AKI was observed among 14.7% patients, predominantly affecting middle-aged males.

Conclusion:

Early recognition of AKI by monitoring for kidney function is crucial for reducing the risk of long-term sequelae of kidney failure among patients taking ATT.

PJKD

Descărcări

Publicat

2025-06-30

Număr

Volum 9 Nr. 2 (2025): Pakistan Journal of Kidney Diseases

Secțiune

Original Article

Licență

Copyright (c) 2025 Madiha Mehmood, Dr Muhammad Anees

Creative Commons License

Această lucrare este licențiată în temeiul Creative Commons Attribution-NonCommercial 4.0 International License.

Cum cităm

Acute Kidney Injury in Patients Receiving Anti-Tuberculosis Treatment. (2025). Pakistan Journal of Kidney Diseases, 9(2), 16-19. https://doi.org/10.53778/pjkd92302